Great Point Partners’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-275,000
| Closed | -$4.99M | – | 30 |
|
|
2025
Q1 | $4.99M | Hold |
275,000
| – | – | 2.64% | 16 |
|
|
2024
Q4 | $6M | Hold |
275,000
| – | – | 2.83% | 16 |
|
|
2024
Q3 | $7.53M | Sell |
275,000
-482,929
| -64% | -$13.2M | 2.22% | 19 |
|
|
2024
Q2 | $19.6M | Buy |
757,929
+132,929
| +21% | +$3.44M | 3.76% | 10 |
|
|
2024
Q1 | $18.8M | Buy |
+625,000
| New | +$18.8M | 2.92% | 16 |
|
|
2022
Q4 | – | Sell |
-63,693
| Closed | -$1.44M | – | 42 |
|
|
2022
Q3 | $1.44M | Sell |
63,693
-9,432
| -13% | -$213K | 0.35% | 36 |
|
|
2022
Q2 | $1.4M | Hold |
73,125
| – | – | 0.34% | 32 |
|
|
2022
Q1 | $3.39M | Hold |
73,125
| – | – | 0.82% | 26 |
|
|
2021
Q4 | $5.18M | Hold |
73,125
| – | – | 1.15% | 29 |
|
|
2021
Q3 | $8.52M | Buy |
73,125
+3,681
| +5% | +$429K | 1.98% | 24 |
|
|
2021
Q2 | $10.9M | Buy |
+69,444
| New | +$10.9M | 2.28% | 19 |
|